de Visser, Yvonne P <br/><br/>
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.  [electronic resource] 

 -  American journal of physiology. Lung cellular and molecular physiology  Jan 2012 
 - L56-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1522-1504 
<br/><br/><label>Standard No.: </label>10.1152/ajplung.00041.2011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Benzamides--pharmacology<br/>Bronchopulmonary Dysplasia--drug therapy<br/>Cyclic Nucleotide Phosphodiesterases, Type 4--metabolism<br/>Disease Models, Animal<br/>Heart--drug effects<br/>Heart Injuries--drug therapy<br/>Humans<br/>Hyperoxia--drug therapy<br/>Hypertension, Pulmonary--drug therapy<br/>Hypertrophy, Right Ventricular--drug therapy<br/>Infant, Newborn<br/>Lung--drug effects<br/>Oxidative Stress--drug effects<br/>Oxygen--pharmacology<br/>Phosphodiesterase 4 Inhibitors--pharmacology<br/>Pulmonary Alveoli--drug effects<br/>Pyridines--pharmacology<br/>Rats